These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6258269)

  • 1. Some enzyme and hormonal attributes of hepatoma cell membranes.
    Mourelle M; Morris HP; Rubalcava B
    Toxicology; 1980; 15(3):173-80. PubMed ID: 6258269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal changes and adenylate cyclase system in rat bearing 7800 Morris hepatoma.
    Mourelle M
    J Appl Toxicol; 1983 Feb; 3(1):9-13. PubMed ID: 6348140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of glucagon receptors in Morris hepatoma 7800.
    Mourelle M; Rojkind M
    Hepatology; 1984; 4(3):515-9. PubMed ID: 6327489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential alterations in the hepatic content and metabolism of cyclic AMP and cyclic GMP induced by DL-ethionine: evidence for malignant transformation of liver with a sustained increase in cyclic AMP.
    DeRubertis FR; Craven PA
    Metabolism; 1976 Dec; 25(12):1611-25. PubMed ID: 186692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglucagonemia and altered responsiveness of hepatic adenylate cyclase-adenosine 3',5'-monophosphate system to hormonal stimulation during chronic ingestion of DL-ethionine.
    Craven PA; Derubertis FR
    Biochim Biophys Acta; 1977 Apr; 497(2):415-27. PubMed ID: 192313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin and glucagon receptors in Morris hepatomas of varying growth rates.
    Pezzino V; Vigneri R; Siperstein MD; Goldfine ID
    Cancer Res; 1979 May; 39(5):1443-6. PubMed ID: 218727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the mouse major histocompatibility complex, H-2, on liver adenylate cyclase activity and on glucagon binding to liver cell membranes.
    Lafuse W; Edidin M
    Biochemistry; 1980 Jan; 19(1):49-54. PubMed ID: 6243475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the adenylate cyclase system in transplantable hepatomas.
    Criss WE; Morris HP
    Cancer Res; 1976 May; 36(5):1740-3. PubMed ID: 178431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus.
    Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
    J Clin Invest; 1984 Apr; 73(4):1013-23. PubMed ID: 6323532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the epinephrine-mediated activation of adenylate cyclase in plasma membranes from liver and ascites hepatomas of rats.
    Okamura N; Terayama H
    Biochim Biophys Acta; 1976 Dec; 455(2):297-314. PubMed ID: 187240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.
    Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
    J Clin Invest; 1984 Apr; 73(4):1004-12. PubMed ID: 6323531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of urea cycle enzymes in transplantable hepatomas and in the livers of tumor-bearing rats and humans.
    Brebnor LD; Grimm J; Balinsky JB
    Cancer Res; 1981 Jul; 41(7):2692-9. PubMed ID: 6265064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased glucagon-stimulated cyclic AMP production by isolated liver cells of rats with type 2 diabetes.
    Portha B; Chamras H; Broer Y; Picon L; Rosselin G
    Mol Cell Endocrinol; 1983 Sep; 32(1):13-26. PubMed ID: 6313452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of glucagon receptors in Golgi fractions of rat liver: evidence for receptors that are uncoupled from adenylyl cyclase.
    Lipson KE; Kolhatkar AA; Cherksey BD; Donner DB
    Biochemistry; 1986 May; 25(9):2612-20. PubMed ID: 3013309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of hepatic insulin and glucagon receptors and adenylate cyclase in rabbit.
    Ganguli S; Sinha MK; Sterman B; Harris P; Sperling MA
    Am J Physiol; 1983 Jun; 244(6):E624-31. PubMed ID: 6305205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on regenerating liver and hepatoma plasma membranes--II. Membrane fluidity and enzyme activity.
    Mahler SM; Wilce PA; Shanley BC
    Int J Biochem; 1988; 20(6):613-9. PubMed ID: 2839384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative adenylate cyclase activities in homogenate and plasma membrane fractions of Morris hepatoma 5123tc (h).
    Hickie RA; Jan SH; Datta A
    Cancer Res; 1975 Mar; 35(3):596-600. PubMed ID: 163685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenylate cyclase activity in plasma membranes of chicken liver and of Mc-29 virus induced hepatoma.
    Chelibonova-Lorer H; Hadjiivanova N; Gavazova E
    Int J Biochem; 1982; 14(10):887-90. PubMed ID: 7128905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of the components of the cyclic nucleotide system in N-nitrosodiethylamine-induced hepatic carcinogenesis in rats].
    Antonenko SG; Berdinskikh NK; Mishnaevskaia EG
    Eksp Onkol; 1990; 12(5):18-21. PubMed ID: 2171896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulin-treated diabetic rats.
    Soman V; Felig P
    J Clin Invest; 1978 Mar; 61(3):552-60. PubMed ID: 205552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.